Medical Expert - Suzanne Craft, PhD

Area of Expertise: Alzheimer’s Disease
Media Contact: Marguerite Beck
Media Office: 336-716-2415 Media Mobile: 336-480-8599
Patient Contact: Health On-Call® 1-800-446-2255
Craft, Suzanne

Suzanne Craft, PhD

Professor of Internal Medicine, Section on Gerontology and Geriatric Medicine; Research Director of the J. Paul Sticht Center on Aging; and Co-director of the Roena B. Kulynych Center for Memory and Cognition Research

Craft is a neuropsychologist with specialization in neuroendocrinology and neuroscience. Her research has focused on the role of neuroendocrine abnormalities in the development and expression of Alzheimer’s disease. This original line of work has garnered international attention, and Craft is recognized as a leading authority on the role of insulin metabolism in Alzheimer’s disease and aging. Her research recently has been expanded to examine the role of insulin in the pathophysiology of Alzheimer’s.

Craft received a $7.9 million National Institutes of Health (NIH) grant in 2011 to lead a multi-center study investigating the use of intranasal insulin in individuals with mild cognitive impairment or mild Alzheimer’s dementia. It was one of two projects selected by the NIH as part of the National Alzheimer’s Plan, a federal initiative to find an effective way to prevent or treat Alzheimer’s by 2025.

Craft’s honors and awards include a MERIT Award from the National Institute on Aging and the Alzheimer’s Association’s 2010 Zenith Award. She also has been Pfizer Visiting Professor at Johns Hopkins University and was a featured scientist in the HBO documentary series “The Alzheimer’s Project.” In addition to her extensive research and numerous publications, Craft serves on a number of editorial boards and national review panels and committees.


Alzheimer's Disease, Insulin Metabolism, Neuroendocrinology


Hartman Foundation Challenge Grant Strengthens Research in Alzheimers Disease
A $1 million challenge grant from the Hartman Foundation of Austin, Texas, is helping researchers at Wake Forest Baptist Medical Center as they study Alzheimer’s disease.
Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment Alzheimers Dementia
Synthetic insulin nasal spray may improve working memory, other mental capabilities, in adults with mild cognitive impairment and Alzheimer’s disease dementia.
Wake Forest Baptist May Awards and Recognitions

Wake Forest Baptist Medical Center faculty, staff, programs and departments that have received awards or been recognized in the past month.

Wake Forest Baptist November Awards and Recognitions Vol 2

Wake Forest Baptist Medical Center faculty, staff, programs and departments that have been recognized by external entities in the past month.

Wake Forest Baptist Receives Gifts to Support Work in Aging and Alzheimers
Three donors have provided gifts totaling nearly $3.5 million to advance education, patient care and research in aging and Alzheimer’s disease at Wake Forest Baptist Medical Center.

Related Experts

Laura D. Baker, PhD
Associate Professor, Section on Gerontology and Geriatric Medicine, and of Public Health Sciences in the Department of Epidemiology and Prevention
Area of Expertise: Alzheimer’s Disease

Medical Expert Laura D. Baker, PhD

USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.